WallStSmart

JBS N.V. (JBS)vsLifevantage Corporation (LFVN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

JBS N.V. generates 39962% more annual revenue ($84.15B vs $210.05M). LFVN leads profitability with a 3.7% profit margin vs 2.5%. LFVN trades at a lower P/E of 7.6x. LFVN earns a higher WallStSmart Score of 54/100 (C-).

JBS

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 5.7Quality: 5.5
Piotroski: 4/9Altman Z: 2.40

LFVN

Buy

54

out of 100

Grade: C-

Growth: 2.7Profit: 6.5Value: 7.3Quality: 8.0
Piotroski: 4/9Altman Z: 2.66
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

JBSSignificantly Overvalued (-132.0%)

Margin of Safety

-132.0%

Fair Value

$7.00

Current Price

$15.75

$8.75 premium

UndervaluedFair: $7.00Overvalued
LFVNSignificantly Overvalued (-24.8%)

Margin of Safety

-24.8%

Fair Value

$4.08

Current Price

$4.29

$0.21 premium

UndervaluedFair: $4.08Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JBS3 strengths · Avg: 8.3/10
Return on EquityProfitability
24.1%9/10

Every $100 of equity generates 24 in profit

P/E RatioValuation
13.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.0x8/10

Reasonable price relative to book value

LFVN4 strengths · Avg: 9.3/10
PEG RatioValuation
0.3610/10

Growing faster than its price suggests

P/E RatioValuation
7.6x10/10

Attractively priced relative to earnings

Return on EquityProfitability
25.0%9/10

Every $100 of equity generates 25 in profit

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Areas to Watch

JBS3 concerns · Avg: 2.0/10
Profit MarginProfitability
2.5%3/10

2.5% margin — thin

EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

Debt/EquityHealth
2.561/10

Elevated debt levels

LFVN4 concerns · Avg: 2.8/10
Market CapQuality
$58.08M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
3.7%3/10

3.7% margin — thin

Operating MarginProfitability
0.4%3/10

Operating margin of 0.4%

Revenue GrowthGrowth
-27.8%2/10

Revenue declined 27.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : JBS

The strongest argument for JBS centers on Return on Equity, P/E Ratio, Price/Book. Revenue growth of 13.4% demonstrates continued momentum.

Bull Case : LFVN

The strongest argument for LFVN centers on PEG Ratio, P/E Ratio, Return on Equity. PEG of 0.36 suggests the stock is reasonably priced for its growth.

Bear Case : JBS

The primary concerns for JBS are Profit Margin, EPS Growth, Debt/Equity. Debt-to-equity of 2.56 is elevated, increasing financial risk. Thin 2.5% margins leave little buffer for downturns.

Bear Case : LFVN

The primary concerns for LFVN are Market Cap, Profit Margin, Operating Margin. Thin 3.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

JBS is growing revenue faster at 13.4% — sustainability is the question.

JBS generates stronger free cash flow (543M), providing more financial flexibility.

Monitor PACKAGED FOODS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

LFVN scores higher overall (54/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JBS N.V.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

JBS N.V., is a protein and food company globally. The company is headquartered in Amstelveen, Netherlands.

Lifevantage Corporation

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

LifeVantage Corporation is dedicated to the identification, research, development and distribution of nutrigenomic activators, dietary supplements, nootropics, pre and probiotics, weight management, and skin and hair care products. The company is headquartered in Sandy, Utah.

Visit Website →

Want to dig deeper into these stocks?